390 related articles for article (PubMed ID: 30340072)
1. Circulating PD-1
Zhang L; Li H; Ren H; Hu P
Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072
[TBL] [Abstract][Full Text] [Related]
2. Increased CCR7
Huang YX; Zhao QY; Wu LL; Xie DY; Gao ZL; Deng H
Can J Gastroenterol Hepatol; 2018; 2018():1020925. PubMed ID: 30402448
[TBL] [Abstract][Full Text] [Related]
3. High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B.
Feng J; Lu L; Hua C; Qin L; Zhao P; Wang J; Wang Y; Li W; Shi X; Jiang Y
PLoS One; 2011; 6(7):e21698. PubMed ID: 21750724
[TBL] [Abstract][Full Text] [Related]
4. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
5. Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.
Zhang L; Zhang M; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
Mol Immunol; 2016 May; 73():37-45. PubMed ID: 27037894
[TBL] [Abstract][Full Text] [Related]
6. Increased Circulating Follicular Regulatory T-Like Cells May Play a Critical Role in Chronic Hepatitis B Virus Infection and Disease Progression.
Wu X; Su Z; Cai B; Yan L; Li Y; Feng W; Wang L
Viral Immunol; 2018 Jun; 31(5):379-388. PubMed ID: 29683413
[TBL] [Abstract][Full Text] [Related]
7. Expansion of circulating TFH cells and their associated molecules: involvement in the immune landscape in patients with chronic HBV infection.
Hu TT; Song XF; Lei Y; Hu HD; Ren H; Hu P
Virol J; 2014 Mar; 11():54. PubMed ID: 24655429
[TBL] [Abstract][Full Text] [Related]
8. [Observation of PD-1
He J; Yao YQ; Xia RX; Qiu TJ; Long L; Wang Y; Jiang Y
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):316-322. PubMed ID: 35462489
[No Abstract] [Full Text] [Related]
9. Programmed death 1 expressing CD8
Khanam A; Tang LSY; Kottilil S
Hepatology; 2022 Mar; 75(3):690-708. PubMed ID: 34689344
[TBL] [Abstract][Full Text] [Related]
10. Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy.
Zhang M; Zhang L; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
Int Immunopharmacol; 2016 May; 34():235-243. PubMed ID: 26971227
[TBL] [Abstract][Full Text] [Related]
11. Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsets.
Ji L; Wei J; Zhang R; Zhang X; Gao Y; Fang M; Yu Z; Cao L; Gao Y; Li M
J Ethnopharmacol; 2024 Jun; 328():118072. PubMed ID: 38508431
[TBL] [Abstract][Full Text] [Related]
12. CXCL13-mediated recruitment of intrahepatic CXCR5
Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
[TBL] [Abstract][Full Text] [Related]
13. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
[TBL] [Abstract][Full Text] [Related]
14. Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection.
Li Y; Ma S; Tang L; Li Y; Wang W; Huang X; Lai Q; Zhang M; Sun J; Li CK; Abbott WG; Naoumov NV; Zhang Y; Hou J
Hepatology; 2013 Oct; 58(4):1277-86. PubMed ID: 23703545
[TBL] [Abstract][Full Text] [Related]
15. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
16. Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients.
Pang X; Zhang L; Liu N; Liu B; Chen Z; Li H; Chen M; Peng M; Ren H; Hu P
Clin Exp Immunol; 2020 Oct; 202(1):80-92. PubMed ID: 32638357
[TBL] [Abstract][Full Text] [Related]
17. Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.
Sonneveld MJ; Hansen BE; Piratvisuth T; Jia JD; Zeuzem S; Gane E; Liaw YF; Xie Q; Heathcote EJ; Chan HL; Janssen HL
Hepatology; 2013 Sep; 58(3):872-80. PubMed ID: 23553752
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expansion of circulating CD4
Zhang L; Li W; Cai Y; Liu X; Peng Q; Liang L
Int J Rheum Dis; 2020 Mar; 23(3):397-405. PubMed ID: 31883219
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
20. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]